Naver's Kream integrates with Japan's Soda

Naver Corp.'s subsidiary Kream, the South Korean limited-edition goods trading platform has decided to merge its operations with Japan's Soda Inc., ...

SK Telecom enters Japan's pet care market

South Korea’s SK Telecom Co. has entered the Japanese pet market using its innovative artificial intelligence (AI) under a tie-up with Japan&r...

Samsung, Japan's KDDI co-work for 5G network slicing tech

Samsung Electronics Co. announced on Wednesday that it has signed a business agreement with Japanese mobile communications company KDDI to jointly d...

Celltrion Pharm gets GMP certification from Japan

Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...

Celltrion gets sales approval for Yuflyma in Japan

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labou...

Celltrion signs largest-ever quarterly deal with global sales affiliate

Celltrion Inc., a South Korean biopharmaceutical giant, said Monday it will provide biosimilars worth 423.6 billion won ($323.6 million), its larges...

S.Korean startups, VC seek money, business opportunities in Japan

South Korean startups and venture capitalists battered by chilled investor sentiment amid rising interest rates and slowing economic growth at home ...

Japanese steelmakers flood South Korea on back of weaker yen

Japanese steelmakers are expanding their market shares in South Korea, backed by the yen's drop against the Korean won to the lowest in eight years....

Live commerce app Grip aims to expand into Japan, US in 2024

Imagine you're using a shopping app. You talk to the seller, ask questions and receive answers in real-time on a livestream video. Now and then, the...

Celltrion Healthcare to supply Yuflyma to five regional gov’ts in Italy

South Korea's Celltrion Healthcare Co. announced on Monday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatm...

Celltrion builds clinical data bank for new biosimilars

The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...

Plasmapp to export 12.3 mn worth of sterilizers to Japan

South Korea's bioplasma technology firm Plasmapp announced on Friday that it has signed a product supply contract worth 16.4 billion won ($12.3 mill...

Korea Inc. to focus more on India, Vietnam as biz partners

South Korean companies are set to concentrate more on business with emerging markets including India and Vietnam than Asian major countries such as ...

Amorepacific's Hera enters Japanese market

South Korea's Amorepacific Corp. announced on Thursday that its premium color cosmetics brand Hera has launched in Japan, signaling a significant mo...

Celltrion to expand new plant for drug products

South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday that it plans to enlarge its finished pharmaceuticals manufacturing facility...

Korea ranks 3rd on global dominant product list to tie Japan

TOKYO -- South Korea has ranked third among countries having the world’s most dominant products. In six categories, including smartphones, mem...

Home & Shopping, Teleken signs business agreement

South Korea's TV and online shopping operator Home & Shopping Co. announced on Friday that it has signed a business agreement with the Japanese ...

Japan's fever for Korean homegrown brands on the rise

Shimamura Co., Japan’s second-largest apparel company that runs around 2,200 stores nationwide, has dispatched a team of four buyers to Seoul ...

Amorepacific's Aestura to enter Japanese market

South Korean beauty and cosmetics giant Amorepacific Corp. announced on Wednesday that its derma cosmetic brand Aestura will enter the Japanese mark...

Celltrion to release Stelara biosimilar in US from March 2025

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it has completed a patent agreement with Johnson & Johnson, the m...

Celltrion considers listing holding firm after merger of 3 units

South Korean drug giant Celltrion Group will consider listing its holding company if necessary, after it completes the merger of three affiliates &n...

HLB signs with Japan's OSCL for exclusive supply of C-Trelin ingredient

South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has entered into a business agreement with Japan's Osaka Syn...

Celltrion’s Vegzelma listed on prescription of 10 private US insurers

South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...

Celltrion gets OK partial approval for phase 3 of biosimilar in Europe

South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...

Celltrion to merge with global sales affiliate by end-2023

South Korean pharmaceutical giant Celltrion Group has begun procedures to merge biopharmaceuticals developer and producer Celltrion Inc. with global...

Camp David Summit to Unite U.S., South Korea, Japan

WASHINGTON—A new trilateral alliance linking the U.S., South Korea and Japan will enhance cooperation among the nations in key areas, includin...

S.Korea is far more reliant on China for rare earth metal than Japan: report

South Korea is far more dependent than Japan on neodymium permanent magnets from China at 88%, while the rate for Japan, a land devoid of rare earth...

Seven out of 10 int'l travelers choose Japan: Yanolja reports

Osaka, followed by other Japanese cities, is the top international choice for South Korean travelers, while domestically, Jeju Island remains the fa...

S.Korea's No. 1 flight route in 2023 is Incheon-Osaka

South Korea's most popular international flight route in the first half of this year was between Incheon International Airport and Kansai Internatio...

Toray Advanced Materials reviews film line expansion in S.Korea

Toray Advanced Materials Korea Inc. (TAK) is reviewing its film line expansion in South Korea as part of its 300 billion won ($229 million) capital ...